DITTA releases cybersecurity white paper
The Global Diagnostic Imaging, Healthcare IT, and Radiation Therapy Trade Association...Read more on AuntMinnie.comRelated Reading: DITTA endorses refurbishment standards JIRA begins 2-year chairmanship of DITTA Imaging groups form global organization COCIR, JIRA, and MITA collaborate (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 22, 2016 Category: Radiology Source Type: news

Indications for Adjuvant Radiation Therapy in Breast Cancer Indications for Adjuvant Radiation Therapy in Breast Cancer
What is the evidence for adjuvant radiotherapy for different types of breast cancer?Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 21, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

CARTI Losses Bring Worry, Advice for Financial Cure Inside New Center
CARTI already was experiencing operating losses before it opened its $88 million cancer center in west Little Rock last November. In the months since then, Central Arkansas Radiation Therapy Institute Inc. has seen its operating losses widen to $20.5 million over the last three fiscal years and missed a financial benchmark for its $49 million bond, which forced it to hire a management consulting firm. Whether it is back on track remains to be seen. CARTI President and CEO Jan Burford recently told Arkansas Business that she is concerned because in the first quarter of its fiscal year that began July 1, the outpatient cance...
Source: Arkansas Business - Health Care - November 21, 2016 Category: American Health Source Type: news

New Interest in Local Therapy for Metastatic Prostate Cancer New Interest in Local Therapy for Metastatic Prostate Cancer
A new study has prostate cancer specialists taking another look at the addition of radiation therapy to primary therapy in metastatic prostate cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 11, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Siemens plans to spin off healthcare as separate business
German industrial giant Siemens is planning to spin off its Siemens Healthineers...Read more on AuntMinnie.comRelated Reading: Siemens installs 1st Somatom Drive CT scanner in U.S. SyntheticMR, Siemens collaborate on MRI scanners IBM Watson unites with Siemens in population health play Siemens to launch CT for radiation therapy at ASTRO Siemens brings new ultrasound systems to CanadaComments: 11/10/2016 2:45:01 PMwoodruGL Siemens has been in the process of dumping Healthcare for many years since they had the rub with the Feds regarding taking folks to dinner etc years ago.  They dumped their I.T. offerings...
Source: AuntMinnie.com Headlines - November 10, 2016 Category: Radiology Source Type: news

Augmenix scores reimbursement code for SpaceOar
Augmenix said today it won a category 1 current procedural terminology reimbursement code from the American Medical Association for periprostatic implantation of biodegradable material, covering its flagship SpaceOAR device. The SpaceOar is designed to separate the prostate from the rectal wall during radiation treatment for prostate cancer, Augmenix said. The device is delivered through a small needle as a liquid, which then solidifies into a soft gel that expands the space between the prostate and rectum during radiotherapy. The substance then liquefies and is absorbed and cleared from the body in the patient&r...
Source: Mass Device - November 9, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Urology Augmenix Inc. Source Type: news

Suppressing protein alleviates radiation-induced bone loss in animal model
New research may hold a clue to curtailing the feared side effect of cancer patients receiving radiation therapy being at high risk of losing bone density and suffering from broken bones within the radiation field during their lifetimes. Suppressing a bone specific protein via its neutralizing antibody alleviates radiation-induced bone loss in an animal model. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 7, 2016 Category: Science Source Type: news

Suppressing protein alleviates radiation-induced bone loss in animal model
(University of Pennsylvania School of Medicine) New research may hold a clue to curtailing the feared side effect of cancer patients receiving radiation therapy being at high risk of losing bone density and suffering from broken bones within the radiation field during their lifetimes. Suppressing a bone specific protein via its neutralizing antibody alleviates radiation-induced bone loss in an animal model. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 7, 2016 Category: Global & Universal Source Type: news

International Celebration Spotlights Breast Imaging Advances
Washington, DC— On Tuesday, Nov. 8, more than 140 medical societies worldwide will mark theInternational Day of Radiology (IDoR), celebrating the thousands of lives saved by the many contributions of breast imagers and radiation oncologists.IDoR 2016 will spotlight breast imaging and the essential role that radiology plays in the detection, diagnosis and management of breast disease. This special day, commemorating the 121st anniversary of the discovery of the X-ray by German physicist Wilhelm Roentgen, is sponsored by theAmerican College of Radiology (ACR),Radiological Society of North America (RSNA) andEuropean Soc...
Source: American College of Radiology - November 1, 2016 Category: Radiology Source Type: news

SyntheticMR, Siemens collaborate on MRI scanners
Swedish medical imaging software developer SyntheticMR has teamed up with Siemens...Read more on AuntMinnie.comRelated Reading: IBM Watson unites with Siemens in population health play Siemens taps customer services executive Siemens to launch CT for radiation therapy at ASTRO SyntheticMR teams with Philips SyntheticMR teams with MD Anderson SyntheticMR signs Cincinnati Children's (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 31, 2016 Category: Radiology Source Type: news

Penn study shows how some intestinal cells resist chemotherapy and radiation
(University of Pennsylvania) When treating cancer with chemotherapy and radiation, decisions about dose must walk a fine line between attacking cancerous cells and preserving healthy ones. Overly aggressive radiation therapy to the torso, for example, can damage the epithelial cells that line the intestines, leading to chronic gastrointestinal problems. A new study from the University of Pennsylvania now shows how some intestinal cells can withstand chemotherapy and radiation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 31, 2016 Category: Global & Universal Source Type: news

Report: Voice box prostheses may only last three months
(Reuters) – Tracheoesophageal voice prosthetic devices often last less than 3 months before they need to be replaced, which is a shorter lifespan than previously reported, according to a new study. “In an ideal setting, voice prostheses should last at least six months and even more ideally, up to one year,” said lead author Jan S. Lewin of The University of Texas MD Anderson Cancer Center in Houston. “In reality, they generally last somewhere about three months before they have to be replaced.” The silicone devices are placed in the shared wall between the trachea and the esophagus after ...
Source: Mass Device - October 5, 2016 Category: Medical Equipment Authors: MassDevice Tags: Clinical Trials Implants Otolaryngology Ear, Nose & Throat Source Type: news

Shortened RT works for low-risk prostate cancer patients
A shortened, higher-dose radiation therapy (RT) protocol is safe for low-risk...Read more on AuntMinnie.comRelated Reading: ASTRO: PET predicts outcomes in vulvar cancer patients ASTRO: Radiation boost cuts local recurrence in DCIS patients ASTRO: Negative PET/CT doesn't always mean dormant NSCLC ASTRO: Prostate cancer has 3 molecular subtypes ASTRO: OK to cut RT dose for primary medulloblastoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 4, 2016 Category: Radiology Source Type: news

Antibody drug conjugates may help personalize radiotherapy for patients with cancer
(University of California - San Diego) Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 4, 2016 Category: Cancer & Oncology Source Type: news

Shortened radiation therapy schedule effective in patients with low-risk prostate cancer
(NRG Oncology) NRG Oncology investigators found delivering higher doses of radiation therapy over 13 fewer days than conventional therapy was safe, more convenient for patients, and was associated with lower costs and similar quality of life outcomes for patients with favorable-risk prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2016 Category: Cancer & Oncology Source Type: news

Addition of EBT to brachytherapy does not produce superior PFS results
(NRG Oncology) NRG Oncology researchers reported that adding external radiation therapy to standard brachytherapy did not improve progression-free survival for men with intermediate-risk prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2016 Category: Cancer & Oncology Source Type: news

Intensity modulated pelvic radiation therapy reduces patient reported toxicities
(NRG Oncology) NRG Oncology investigators report better patient-reported quality of life measures for women who received intensity modulated radiation therapy (IMRT) for their pelvic radiation therapy (RT) than those who received standard RT. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2016 Category: Cancer & Oncology Source Type: news

Death While on Radiation Therapy Death While on Radiation Therapy
There's never been a study of cancer patients who die during radiation therapy. Until now.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 29, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Is IMRT for Gynecologic Cancers Less Toxic? Is IMRT for Gynecologic Cancers Less Toxic?
Pelvic IMRT reduces acute patient-reported toxicity compared to standard pelvic radiation therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Radiation therapy for cancer causes brain damage, disrupting taste and smell
(NaturalNews) Doctors have known for some time that radiation treatment for cancers of the head and neck can often result in changes to a patient's sense of smell or taste, but they have attributed this effect mostly to temporary destruction of taste buds. But according to a study... (Source: NaturalNews.com)
Source: NaturalNews.com - September 28, 2016 Category: Consumer Health News Source Type: news

SBRT Doubled Survival Rates in Stage I NSCLC at VA SBRT Doubled Survival Rates in Stage I NSCLC at VA
Analysis of VA databases reveals dramatic improvement in survival with stereotactic body radiation therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 27, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Link between facility volume, radiation outcomes for head and neck cancers
The association between provider case volume and outcomes has long been suggested in cancer care. A research team has completed a review of outcomes for patients with locally advanced squamous cell head and neck cancers treated with intensity-modulated radiation therapy (IMRT) and found a distinct association between higher-volume treatment centers and improved overall survival. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 27, 2016 Category: Science Source Type: news

ASTRO: Outreach boosts radiation therapy rates for blacks
BOSTON - A patient outreach program essentially eliminated the treatment gap...Read more on AuntMinnie.comRelated Reading: ASNR 2016: Race and sex affect who gets brain imaging Delayed rad therapy puts women with DCIS at risk Socioeconomic factors affect patient care in radiology Racial discrepancies persist in breast cancer diagnoses (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2016 Category: Radiology Source Type: news

New type of radiation treatment may up survival for older lung cancer patients
Dennis Thompson, HealthDay News A new radiation therapy seems to boost survival for older people with early stage lung cancer who aren't strong enough for surgery, a pair of studies suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 26, 2016 Category: Consumer Health News Source Type: news

This May Up Survival for Some Lung Cancer Patients
2 new studies find benefit to using stereotactic body radiation therapy (Source: WebMD Health)
Source: WebMD Health - September 26, 2016 Category: Consumer Health News Source Type: news

New Type of Radiation Treatment May Up Survival for Older Lung Cancer Patients
2 new studies find benefit to using stereotactic body radiation therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 26, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Geriatrics, News, Source Type: news

Shortened Radiation Therapy Offers Similar Quality of Life for Low-Risk Prostate Cancer Patients
Low-risk prostate cancer patients may be able to undergo a shortened course of radiation therapy that cuts treatment by weeks and offers comparable outcomes and quality of life results as those who undergo longer treatment courses. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 26, 2016 Category: Science Source Type: news

ASTRO: OK to cut RT dose for primary medulloblastoma
Reduced doses for radiation therapy (RT) for pediatric medulloblastoma at the...Read more on AuntMinnie.comRelated Reading: Pediatric proton therapy treatments on the rise SNMMI: PET, MRI may predict pediatric brain tumor outcomes ASTRO: Study lauds proton therapy Imaging advances therapy assessment Proton therapy offers hope to pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 26, 2016 Category: Radiology Source Type: news

Widespread adoption of SBRT has improved survival rates for elderly patients with early stage lung cancer
Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 26, 2016 Category: Science Source Type: news

New Type of Radiation Treatment May Up Survival for Older Lung Cancer Patients
MONDAY, Sept. 26, 2016 -- Cutting-edge radiation therapy seems to provide a significant survival advantage for older people with early stage lung cancer who aren't strong enough for surgery, a pair of new studies suggests. The therapy is called... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 26, 2016 Category: Journals (General) Source Type: news

How much is enough: two new priority review updates on radiotherapy for breast cancer
 Reposted with permission from Cochrane AustraliaFor many women with breast cancer, the use of post-operative radiotherapy will allow them to undergo less extensive surgery. In mid-July, Brisbane-based Radiation Oncologist Brigid Hickey and colleagues from Australia and New Zealand published two review updates that consider critical questions about the size of the doses in which radiation is given. Here, Brigid shares her thoughts on the important findings of both reviews.‘So who gets breast cancer? Women with families, women with jobs, women with busy lives,’ says Brigid. ‘So from a patient perspect...
Source: Cochrane News and Events - September 26, 2016 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

New Type of Radiation Treatment May Up Survival for Older Lung Cancer Patients
2 new studies find benefit to using stereotactic body radiation therapy (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - September 26, 2016 Category: Cancer & Oncology Source Type: news

ZDi introduces radiation therapy positioning devices
Medical device developer ZDi Solutions is launching a line of patient positioning...Read more on AuntMinnie.com (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 23, 2016 Category: Radiology Source Type: news

Vision RT touts data showing less harmful radiotherapy
Radiation therapy software developer Vision RT is directing attention to new...Read more on AuntMinnie.comRelated Reading: Vision RT appoints new sales VP for EMEA, Asia Pacific CIVCO adds integration with Vision RT Vision RT adds U.S. customers Vision RT opens N. American support center Vision RT signs on Varian (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 23, 2016 Category: Radiology Source Type: news

ZDI Introduces Patented Proton Therapy and Radiation Therapy Positioning Devices to Radiation Oncology Market
KNOXVILLE, Tenn., Sept. 23, 2016 -- (Healthcare Sales & Marketing Network) -- ZDi Solutions, LLC announced today that it will soon market its Z-System™ patient positioning devices to proton therapy and conventional radiation therapy facilities in the U.S.... Devices, Oncology, Product Launch ZDi Solutions, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 23, 2016 Category: Pharmaceuticals Source Type: news

[In Depth] Using DNA, radiation therapy gets personal
At most cancer hospitals today, medical oncologists routinely order genetic tests that help guide their drug treatment decisions. But down the hallway in the radiation ward, cancer patients typically get a one-size-fits-all course of radiotherapy, regardless of their genetics or those of their cancer. A small but increasing number of radiation oncologists is hoping to change that. At the annual meeting of the American Society for Radiation Oncology next week in Boston, researchers will describe their hunt for gene activity profiles in tumors that can help determine how susceptible the cancer will be to radiation. Others ar...
Source: ScienceNOW - September 22, 2016 Category: Science Authors: Elie Dolgin Tags: Cancer Source Type: news

Siemens to launch CT for radiation therapy at ASTRO
Siemens Healthineers plans to launch a new work-in-progress CT scanner for...Read more on AuntMinnie.comRelated Reading: Siemens brings new ultrasound systems to Canada Siemens adds to executive lineup Siemens, InSightec to partner Siemens Healthineers posts flat Q3 numbers Siemens debuts enterprise services for U.S. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 22, 2016 Category: Radiology Source Type: news

Lincoln Pharma launches Ondansetron oral spray in India
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 22, 2016 Category: Pharmaceuticals Source Type: news

New guidelines on radiation therapy for breast cancer
Experts from three leading cancer organizations suggest more patients should consider this treatment option (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 22, 2016 Category: Consumer Health News Source Type: news

Neutrophils are key to harnessing anti-tumor immune response from radiation therapy, study finds
Combining targeted radiation therapy with a neutrophil stimulant enhances anti-tumor immunity, according to new research into cancer immunology. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 21, 2016 Category: Science Source Type: news

More breast cancer patients should get radiation, new guidelines say
Kathleen Doheny, HealthDay News New guidelines issued by three leading cancer organizations suggest that more breast cancer patients should consider radiation therapy after a mastectomy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 21, 2016 Category: Consumer Health News Source Type: news

More Breast Cancer Patients Should Consider Radiation, New Guidelines Say
Mastectomy patients with small tumors, fewer lymph nodes involved, benefit from the therapy, cancer experts agree Source: HealthDay Related MedlinePlus Pages: Breast Cancer, Mastectomy, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 21, 2016 Category: Consumer Health News Source Type: news

More Breast Cancer Patients Should Get Radiation, New Guidelines Say
WEDNESDAY, Sept. 21, 2016 -- New guidelines issued by three leading cancer organizations suggest that more breast cancer patients should get radiation therapy after a mastectomy. Overall, the guidelines say there's enough evidence to show radiation... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 21, 2016 Category: Journals (General) Source Type: news

ScandiDos prepares new QA system for ASTRO 2016
Radiation therapy quality assurance (QA) firm ScandiDos will debut a nonextrapolated...Read more on AuntMinnie.comRelated Reading: FDA clears ScandiDos dosimetry system ScandiDos readies in vivo dosimetry system Elekta signs distributor deal with ScandiDos (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 20, 2016 Category: Radiology Source Type: news

ViewRay wins CE mark for MRIdian Linac scanner
ViewRay (NSDQ:VRAY) said today it won CE Mark approval in the European Union for its MRIdian Linac next-gen linear accelerator-based MRI-guided radiation therapy system. The newly cleared MRIdian Linac device replaces the cobalt it utilized with linear accelerator technology, Cleveland, Ohio-based ViewRay said. “We are excited to have CE Mark approval and to begin selling MRIdian Linac within Europe. We believe the radiation oncology community has been eagerly awaiting the availability of a clinical MRI-guided Linac system, and we’re pleased to bring them ViewRay’s well-established MRI-guid...
Source: Mass Device - September 19, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Imaging Radiosurgery Regulatory/Compliance ViewRay Inc. Source Type: news

Varian releases new version of analytics software
Radiation therapy firm Varian Medical Systems has released version 1.2 of its...Read more on AuntMinnie.comRelated Reading: FDA clears Varian's Nexus DR system Varian touts studies on RapidPlan software Varian adds installation in Bolivia Ohio center opens doors with Varian system Varian creates online group, gets Ethiopia contract (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 19, 2016 Category: Radiology Source Type: news

FDA clears Varian's Nexus DR system
Radiation therapy firm Varian Medical Systems has received 510(k) clearance...Read more on AuntMinnie.comRelated Reading: Varian touts studies on RapidPlan software Varian adds installation in Bolivia Ohio center opens doors with Varian system Varian creates online group, installs in Ethiopia Varian shows slight revenue gain in Q3 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 15, 2016 Category: Radiology Source Type: news

Common breast cancer test may not be worth the cost, UCLA study suggests
A genomic test widely used to help determine whether women with a common form of breast cancer should undergo radiation is not cost effective, according to a new UCLA Jonsson Comprehensive Cancer Center study. The Oncotype DX DCIS test is given to women with ductal carcinoma in situ, which means the cancer has not spread to any other tissues, to help them choose the best treatment by better identifying the potential of tumors to come back.Oncotype DX DCIS reduces the number of women undergoing radiation therapy, which is good because it decreases the number of women exposed to possibly harmful side effects. However, UCLA J...
Source: UCLA Newsroom: Health Sciences - September 13, 2016 Category: Universities & Medical Training Source Type: news

Make the Diagnosis: Mysterious Mass
(MedPage Today) -- Case Findings: A 40-year-old male presents with a painful mass on his left shoulder of 5 months'duration. He has a history of stage IV scleronodular type of Hodgkin's disease that was treated 23 years ago with chemotherapy and radiation therapy. He relapsed a year later, and required another round of chemotherapy followed by autologous hematopoietic stem cell transplantation. He relapsed again the next year, and underwent another chemotherapy regimen and allogeneic stem cell transplantation. He has been disease-free for 20 years. What is your diagnosis? (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - September 13, 2016 Category: Gastroenterology Source Type: news

Varian touts studies on RapidPlan software
Radiation therapy firm Varian Medical Systems' RapidPlan treatment planning...Read more on AuntMinnie.comRelated Reading: Varian adds installation in Bolivia Ohio center opens doors with Varian system Varian creates online group, installs in Ethiopia Varian shows slight revenue gain in Q3 Varian announces name for imaging spin-off (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 12, 2016 Category: Radiology Source Type: news